Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Educational Intervention, Electronic Health Record Review, Internet-Based Intervention, Patient Navigation.
- Who it may be relevant to
- Registry conditions: Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Pilot Trial to Evaluate the Effectiveness of Navigation, Interactive Web Education, or the Combination of Both to Promote Guideline-Concordant Colorectal Cancer Surveillance Care
Overview
This pilot clinical trial looks at whether patient navigation services, an interactive web education intervention, called Current Together After Cancer (CTAC), or both navigation and CTAC works to improve the uptake of surveillance in patients with stage I-III colorectal cancer (CRC). Post-treatment surveillance is critical to detect recurrence early, yet many CRC survivors do not receive recommended surveillance care. Surveillance is a complex process that includes laboratory tests, cross-sectional imaging, and endoscopic procedures. Patient navigation services, interactive web education, or a combination of both may improve surveillance care for patients with stage I-III colorectal cancer.
Detailed description
OUTLINE:
Patients are assigned to 1 of 3 arms based on the clinic location they receive cancer care at.
ARM A (VIRGINIA MASON): Patients receive access to navigation services, including education on surveillance care, reminders to complete care and assistance in scheduling surveillance, within 3 months of standard of care surgical resection for stage I-III CRC.
ARM B (FRED HUTCH \[SOUTH LAKE UNION\]): Patients receive access to the CTAC intervention, which includes self-directed, interactive web-based education about surveillance and a checklist of care, within 3 months of standard of care surgical resection for stage I-III CRC.
ARM C (FRED HUTCH \[OVERLAKE + EVERGREEN\]): Patients receive access to navigation services, including education on surveillance care, reminders to complete care and assistance in scheduling surveillance, and access to the CTAC intervention, which includes self-directed, interactive web-based education about surveillance and a checklist of care, within 3 months of standard of care surgical resection for stage I-III CRC.
Patients are followed up at 3 months post study-enrollment and 12-18 months after surgical resection.
Interventions
- Other Educational Intervention
Complete self-directed interactive education - Other Electronic Health Record Review
Ancillary studies - Other Internet-Based Intervention
Receive access to CTAC - Behavioral Patient Navigation
Receive patient navigation services - Other Survey Administration
Ancillary studies
Primary outcome measures
- Completion of colonoscopy (stage I colorectal carcinoma patients) [Time frame: Up to 18 months post-surgical resection]
- Completing any colonoscopy, carcinoembryonic antigen tumor marker (CEA), and cross-sectional imaging (stage II-III colorectal carcinoma patients) [Time frame: Up to 18 months post-surgical resection]
Secondary outcome measures (5)
- Knowledge of colorectal cancer (CRC) surveillance [Time frame: At baseline, and 3 months post enrollment]
- Self-efficacy to complete CRC surveillance [Time frame: At baseline, and 3 months post enrollment]
- Acceptability of the intervention [Time frame: At 3 months post enrollment]
- Intervention appropriateness [Time frame: At 3 months post enrollment]
- Feasibility of the intervention [Time frame: At 3 months post enrollment]
Eligibility criteria
Inclusion criteria
- Age ≥ 18 due to disease and clinic population
- Stage I-III CRC survivor within 3 months post-surgical resection
- Being seen at a participating clinic
- Ability to understand and complete surveys in English
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Non-randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
United States · 2 centers
- Benaroya Research Institute at Virginia Mason — Seattle
- Fred Hutch/University of Washington Cancer Consortium — Seattle
Identifiers
NCT: NCT06995924 · RG1125283 · NCI-2025-03304 · 20875